Background

Dr. Russell J. Howard, Ph.D was a Co-Founder of Maxygen Inc and served as its Chief Executive Officer from June 1998 to September 30, 2009. After leaving Maxygen in 2008, Dr. Howard started the CleanTech company Oakbio, Inc. and remains involved in a number of other innovative biotechnology companies. Dr. Howard served as President and Chief Operating Officer of Maxygen Inc. since May 1997. Originally trained in biochemistry and chemistry, he has spent over 20 years ... studied infectious diseases, primarily malaria, and serves on the National Institutes of Health and USAID advisory panels for malaria vaccine development. Before joining Maxygen, he served as the President and Scientific Director of Affymax Research Institute, an institute employing combinatorial chemistry and high throughput target screening to discover drug leads from August 1994 to June 1991. Dr. Howard has held positions at a number of leading research laboratories around the world, including the Immunoparasitology Laboratory at the Walter & Eliza Hall Institute in Melbourne and the National Institutes of Health in Bethesda, Maryland, where he became a tenured investigator. Dr. Howard worked at Schering-Plough’s DNAX Research Institute of Molecular and Cellular Biology in Palo Alto, California. He was a pioneer in the field of molecular parasitology and in leading the commercialization of one of the most important methods used widely in molecular biology today called “DNA shuffling“ or “molecular breeding.” He has been a Non Executive Director of Prima Biomed Ltd. since May 8, 2013. He served as a Director of Codexis, Inc. He served as a Director of Biotechnology Industry Organization. He served as a Director of Maxygen Inc. from June 1998 to September 30, 2009. He is a Member of Product Development Review Committee at Circadian Technologies Ltd. He is listed as the inventor on five patents and is the author of over 140 scientific publications. Dr. Howard was the overall winner of the 2013 Advance Global Australian Award for his global impact on the biotechnology field and green chemistry. Dr. Howard holds a B.S. in chemistry and biochemistry, a B.S. in biochemistry (Hons.) and a Ph.D. in biochemistry from the University of Melbourne.

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.